Evidence map›Paper›PMID 30008466›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2018

The Effects of Ludartin on Cell Proliferation, Cell Migration, Cell Cycle Arrest and Apoptosis Are Associated with Upregulation of p21WAF1 in Saos-2 Osteosarcoma Cells In Vitro.

Shuang-Li Zhang, Bao-Lin Li, Wei Li, Ming Lu, Lin-Ying Ni, Hui-Li Ma, Qing-Gang Meng

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2021
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Shuang-Li ZhangHarbin Medical University, Harbin, Heilongjiang, China (mainland).
Bao-Lin LiDepartment of Orthopedics, The First Hospital of Harbin, Harbin, Heilongjiang, China (mainland).
Wei LiDepartment of Orthopedics, The First Hospital of Harbin, Harbin, Heilongjiang, China (mainland).
Ming LuDepartment of Surgical Oncology, The First Hospital of Qiqihaer City, Qiqihaer, Heilongjiang, China (mainland).
Lin-Ying NiDepartment of Orthopedics, Harbin Medical University, Cancer Hospital, Harbin, Heilongjiang, China (mainland).
Hui-Li MaDepartment of Orthopedics, Binzhou Medical University Hospital, Binzhou, Shandong, China (mainland).
Qing-Gang MengHarbin Medical University, Harbin, Heilongjiang, China (mainland).
Harbin Medical University · CNThe First Hospital of Kunming · CNBinzhou University · CNQiqihar Medical University · CNThird Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The aim of this study was investigate the effects of the sesquiterpene lactone, ludartin, on cell proliferation, cell migration, apoptosis, and the cell cycle in osteosarcoma cell lines, compared with a normal osteoblast cell line. MATERIAL AND METHODS Osteosarcoma cell lines, MG-63 Saos-2 U-2OS, T1-73 143B, and HOS, and normal hFOB 1.19 osteoblasts, were cultured and treated with increasing doses of ludartin, The MTT colorimetric assay was used to measure cell metabolic activity and viability. Apoptosis was studied by fluorescence-activated cell sorting (FACS) using 4',6-diamidino-2-phenylindole (DAPI) nuclear staining and Annexin-V/propidium iodide (PI) staining. Cell cycle was studied using flow cytometry. Cell migration and invasion were studied using wound healing and Boyden chamber assays. Protein expression was measured by Western blotting. RESULTS Ludartin inhibited cell viability, cell migration, cell proliferation, and increased cell apoptosis, in all osteosarcoma cell lines, with an IC50 dose ranging from 15-30 µM. The greatest effects were on the Saso-2 osteosarcoma cells, with an IC50 of 15 µM. However, ludartin showed minor cytotoxic effects of the normal hFOB 1.19 osteoblasts (IC50 >100 µM). Ludartin exerted its anti-proliferative effects on Saos-2 cells via induction of apoptosis and cell cycle arrest at the G2/M checkpoint, associated with reduced expression of Cdc25c (Ser216), Cdc25c, pCdc2 (Tyr15), and Cdc2 and increased expression of p21WAF1. Ludartin inhibited cell migration and invasion of the Saos-2 cells. CONCLUSIONS The dose-dependent effects of ludartin on cell proliferation, migration, apoptosis, cell cycle arrest at the G2/M checkpoint involved p21WAFI in Saos-2 osteosarcoma cells.

Indexed as

ApoptosisBone NeoplasmsCell CycleCell Cycle CheckpointsCell Line, TumorCell MovementCell ProliferationCell SurvivalCyclin-Dependent Kinase Inhibitor p21Dose-Response Relationship, DrugHumansOsteoblastsOsteosarcomaSesquiterpenesTranscriptional ActivationUp-RegulationCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21ludartinSesquiterpenes

Identifiers

PMID30008466
PMCPMC6067020
OpenAlexW2883183744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.